Unraveling antibody function: Quantitative approaches to studying antibody function in host-pathogen interactions
Year: 2026
Type: dissertation
Abstract: Human pathogens pose a growing concern, and there is an increasing need to understand the mechanisms underlying infection.While many pathogens typically cause uncomplicated, self-limiting infections, they can sometimes progress to life-threatening conditions such as sepsis.Approximately 50 million cases of sepsis occur annually worldwide and approximately 20 million of them in children under five.Yet little is known about how or why uncomplicated infections sometimes progress to life-threatening disease.As we move toward a post-antibiotic era, in which even minor bacterial infections risk becoming difficult to treat, and in which new antibiotics themselves risk driving further resistance, there is a pressing need for alternative therapeutic strategies that target host-pathogen interactions directly.Antibodies represent one such alternative: they play a crucial role in the natural immune response to infection and have considerable potential as therapeutics against invasive disease, acting by neutralizing pathogens, promoting phagocytosis through opsonization, and activating complement-mediated killing and agglutination.However, the interplay between antibodies and pathogens is complex, and conventional characterization of antibody efficacy through affinity, specificity, and neutralization alone is insufficient to predict functional outcome.This thesis argues that antibody function also depends on context, spatial organization, and molecular geometry.To investigate this, it combines quantitative modeling and microscopy across polyclonal and monoclonal antibody systems, using bacterial infection models involving Group A streptococcus (GAS) Streptococcus pyogenes and viral infection models involving severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).The first part shows that GAS surface proteins compete with antigen-specific antibodies for Fc engagement, and that functional antibody orientation depends on the composition of the surrounding polyclonal repertoire.We describe this using a theoretical model that is implemented on patient-derived antibodies, showing that antibody avidity and concentration do not necessarily correspond to functional immune outcome.The second part introduces SiteLoc, a nanometre-precision imaging-based approach for localizing antibody binding on native bacterial surfaces.Using SiteLoc to characterize monoclonal patient-derived samples revealed that bivalent engagement on two distinct epitopes enhances immune function independent of binding strength.The third part examines antibody molecular architecture itself: class-switching a SARS-CoV-2 monoclonal antibody from IgG1 to IgA1/IgA2 revealed how isotype-dependent flexibility and reach influence avidity and epitope coverage, and quantitative fluorescence anisotropy microscopy captured the dynamic orientation of this antibody during Fcγ receptor engagement on living cells.Together, these studies demonstrate that antibody function reflects the interplay of repertoire composition, spatial geometry, and molecular architecture across different pathogens and environments.The quantitative approaches developed here provide tools that can help guide the design of more effective antibody-based therapeutics and vaccines.
Author: Kumra Ahnlide, Vibha
Institution: Lund University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7214267423
